137 related articles for article (PubMed ID: 23836473)
1. Metastatic bone disease: Have we improved after a decade of guidelines?
Harvie P; Whitwell D
Bone Joint Res; 2013; 2(6):96-101. PubMed ID: 23836473
[TBL] [Abstract][Full Text] [Related]
2. The British Orthopaedic Oncology Management (BOOM) audit.
Archer JE; Chauhan GS; Dewan V; Osman K; Thomson C; Nandra RS; Ashford RU; Cool P; ; Stevenson J
Bone Joint J; 2023 Oct; 105-B(10):1115-1122. PubMed ID: 37777202
[TBL] [Abstract][Full Text] [Related]
3. Communication in surgical decision-making while managing metastatic bone disease: matching patient expectations with surgical goals.
Barton KI; Hazenbiller O; Freeman G; Kashluba K; Ball M; Aboutaha A; Puloski SKT; Monument MJ
Support Care Cancer; 2021 Feb; 29(2):1111-1119. PubMed ID: 32607597
[TBL] [Abstract][Full Text] [Related]
4. A prospective longitudinal study investigating outcomes including patient-reported outcome measures after surgery for metastatic bone disease.
Downie S; Stillie A; Moran M; Sudlow C; Simpson AHRW
Bone Jt Open; 2021 Feb; 2(2):79-85. PubMed ID: 33573398
[TBL] [Abstract][Full Text] [Related]
5. Executive Summary: Clinical Practice Guideline of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in China.
Liu ZH; Li G; Zhang L; Chen J; Chen X; Zhao J; Liang X
Kidney Dis (Basel); 2019 Oct; 5(4):197-203. PubMed ID: 31768376
[TBL] [Abstract][Full Text] [Related]
6. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
[TBL] [Abstract][Full Text] [Related]
7. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
Bakkaloglu SA; Bacchetta J; Lalayiannis AD; Leifheit-Nestler M; Stabouli S; Haarhaus M; Reusz G; Groothoff J; Schmitt CP; Evenepoel P; Shroff R; Haffner D;
Nephrol Dial Transplant; 2021 Feb; 36(3):413-425. PubMed ID: 33245331
[TBL] [Abstract][Full Text] [Related]
8. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Cozzolino M; Ureña-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S;
Nephrol Dial Transplant; 2014 Oct; 29(10):1815-20. PubMed ID: 24516228
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?
Spasovski G; Zdravkovska V; Zabzun M; Antarorov R; Ivanovski K; Janakievska P; Neskovski J; Karceva-Sarajlia E; Panova B; Petrovska T; Zulbeari L; Masin-Spasovska J; Taleska-Matovska N; Gelev S
Int Urol Nephrol; 2012 Dec; 44(6):1791-8. PubMed ID: 22173961
[TBL] [Abstract][Full Text] [Related]
12. British Association of Surgical Oncology Guidelines. The management of metastatic bone disease in the United Kingdom. The Breast Specialty Group of the British Association of Surgical Oncology.
Eur J Surg Oncol; 1999 Feb; 25(1):3-23. PubMed ID: 10188849
[TBL] [Abstract][Full Text] [Related]
13. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
Chuang SH; Wong HC; Vathsala A; Lee E; How PP
Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of metastatic bone disease in the U.S.
Schulman KL; Kohles J
Cancer; 2007 Jun; 109(11):2334-42. PubMed ID: 17450591
[TBL] [Abstract][Full Text] [Related]
16. Management of metastatic bone disease in the elderly with bisphosphonates and receptor activator of NF-kB ligand inhibitors: effectiveness and safety.
Vassiliou V
Clin Oncol (R Coll Radiol); 2013 May; 25(5):290-7. PubMed ID: 23466465
[TBL] [Abstract][Full Text] [Related]
17. What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Known, Diffuse Metastatic Disease to Bone?
Gusho CA; Blank AT
Anticancer Res; 2021 May; 41(5):2473-2476. PubMed ID: 33952473
[TBL] [Abstract][Full Text] [Related]
18. Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.
Toussaint ND; Pedagogos E; Beavis J; Becker GJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2011 Apr; 26(4):1319-26. PubMed ID: 20935019
[TBL] [Abstract][Full Text] [Related]
19. A scoping review on the surgical management of metastatic bone disease of the extremities.
Kendal JK; Abbott A; Kooner S; Johal H; Puloski SKT; Monument MJ
BMC Musculoskelet Disord; 2018 Aug; 19(1):279. PubMed ID: 30081884
[TBL] [Abstract][Full Text] [Related]
20. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.
Nooh A; Goulding K; Isler MH; Mottard S; Arteau A; Dion N; Turcotte R
Clin Orthop Relat Res; 2018 Mar; 476(3):535-545. PubMed ID: 29529637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
